EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Identifying a Novel DPYD Polymorphism Associated with Severe Toxicity to 5‐FU Chemotherapy in a Saudi Patient

Nedal Bukhari iD, Faisal Azam, Mohammed Alfawaz, Mohammed Zahrani

Case Reports in Genetics · 2019-01 · 2019 (1)

DOI: 10.1155/2019/5150725 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Case Reports in Genetics, online erschienen am 21.08.2019. Verfasst von Nedal Bukhari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, King Fahad Specialist Hospital in Dammam, Saudi Arabia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dihydropyrimidine dehydrogenase (DPD) is the major enzyme in the catabolism of 5‐Fluorouracil (5‐FU) and its prodrug capecitabine. We report a 65‐year‐old female with rectal adenocarcinoma who experienced severe toxicities secondary to standard dose 5‐FU based chemotherapy. She was found to be heterozygous for rs371313778, c.2434G>A. This finding prompted restarting 5‐FU at 50% dose reduction with further titration in subsequent cycles. We herein report the first case of rs371313778, c.2434G>A (p.Val812lle) DPYD polymorphism leading to severe 5‐FU toxicities. The patient eventually completed a 6‐month course of adjuvant treatment with modification of 5‐FU dose.

Autor:innen und Institutionen

  • Department of Medical Oncology, King Fahad Specialist Hospital in Dammam, Saudi Arabia.
  • Department of Internal Medicine, King Fahad University Hospital, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
  • Department of Internal Medicine, University of Jeddah, Jeddah, Saudi Arabia.
  • Department of Internal Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.

ORCID-Profile: Nedal Bukhari

Zitieren

APA

Bukhari, N., Azam, F., Alfawaz, M., & Zahrani, M. (2019). Identifying a Novel DPYD Polymorphism Associated with Severe Toxicity to 5‐FU Chemotherapy in a Saudi Patient. Case Reports in Genetics, 2019(1). https://doi.org/10.1155/2019/5150725

Vancouver

Bukhari N, Azam F, Alfawaz M, Zahrani M. Identifying a Novel DPYD Polymorphism Associated with Severe Toxicity to 5‐FU Chemotherapy in a Saudi Patient. Case Reports in Genetics. 2019;2019(1). doi:10.1155/2019/5150725

BibTeX
@article{Bukhari2019,
  author = {Bukhari, Nedal and Azam, Faisal and Alfawaz, Mohammed and Zahrani, Mohammed},
  title = {Identifying a Novel DPYD Polymorphism Associated with Severe Toxicity to 5‐FU Chemotherapy in a Saudi Patient},
  journal = {Case Reports in Genetics},
  year = {2019},
  volume = {2019},
  number = {1},
  doi = {10.1155/2019/5150725}
}
Kostenlos starten →